Printer Friendly

Georgetown University Hospital and UCSF Medical Center Are First to Get Newest Generation CyberKnife(R) Image-Guided Radiosurgery System.

SUNNYVALE, Calif., July 10 /PRNewswire/ --

Accuray Incorporated, the world leader in advanced Image-Guided Radiosurgery, announced today the first two orders for the newest CyberKnife Radiosurgery System, for Georgetown University Hospital and University of California, San Francisco (UCSF) Medical Center. The CyberKnife, which was publicly unveiled for the first time at the American Association of Neurological Surgeons Annual Meeting this past April in Toronto, integrates proprietary image-guidance technology with robotic delivery to target and irradiate tumors with unprecedented accuracy and patient comfort.

UCSF Medical Center, a top-tier institution with an established brain radiosurgery program, has signed a contract to acquire the CyberKnife through the CyberKnife Placement Model (CPM) -- a revenue and risk-sharing joint venture with Accuray -- to expand its radiosurgery program.

Mitchel Berger, M.D., Professor and Chairman of Neurosurgery at UCSF, announces, "I am pleased that UCSF Medical Center has decided to acquire a CyberKnife and is following the vision that Dr. John Adler and I have had of expanding radiosurgery beyond the brain." David Larson, M.D. Ph.D. and William Wara, M.D., Department of Radiation Oncology, agree, "What makes the CyberKnife unique is that it utilizes an image-guidance system which relies on the skeletal system for stereotaxy instead of an unwieldy and uncomfortable immobilization system. By eliminating external localizing devices, this system will potentially enable physicians to use external radiosurgery for the first time to treat tumors with great accuracy throughout the body* and with confidence that patient motion is accounted for."

MedStar Health, the largest healthcare system in the Baltimore/Washington, D.C. region, has obtained the $2.9 million CyberKnife for its Lombardi Cancer Center at Georgetown University Hospital, one of the nation's top cancer centers.

Steven S. Cohen, Senior Vice President of Integrated Operations at MedStar Health, states, "This type of technical innovation is evidence of why our hospitals are nationally ranked and why we are the healthcare provider of choice in this region. Now patients in our network will have a non-invasive treatment option for certain cancers of the brain and spine*."

Thierry Thaure, Senior Vice President of Sales and Marketing at Accuray, concludes, "The outright purchase of the $2.9 million CyberKnife system for Georgetown University Hospital, owned and operated by MedStar Health, and UCSF Medical Center's acquisition through the CyberKnife Placement Model (CPM) are examples of the flexibility we can offer customers. With over 1.2 million new cases of cancer diagnosed in the U.S. alone last year, this has the potential to be a high impact technology for patients around the world."

About Accuray:

The unique CyberKnife system technology was developed in cooperation with Stanford University and was cleared by the Food and Drug Administration (FDA) in 1999 for head, neck, and spine use down to the cervico-thoracic junction. Accuray Incorporated is a privately held corporation located in Sunnyvale, California, the heart of the Silicon Valley. CyberKnife is a registered trademark of Accuray Incorporated. The company designs, manufactures, and distributes the CyberKnife(R) Radiosurgery Systems in the USA and certain markets internationally. Accuray has as its mission to enable full-body radiosurgery using image-guided robotics and to make this technology available to physicians throughout the world.

*The spine (below the cervico-thoracic junction), lung, prostate, and pancreas are currently treated under FDA Investigational Device Exemption (IDE) protocols. FDA 510(k) pre-market notification for treatment of lesions anywhere in the body where radiation is indicated is pending. Currently the CyberKnife is cleared only for head, neck, and cervical spine tumor treatments. These cases represent only a small portion of new tumors that are diagnosed each year.

MAKE YOUR OPINION COUNT - Click Here

http://tbutton.prnewswire.com/prn/11690X64099686
COPYRIGHT 2001 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 10, 2001
Words:606
Previous Article:Quicksilver Resources Added to Russell Index List.
Next Article:Cymer Announces Webcast of Second Quarter Conference Call.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters